Molecular tumor board: molecularly adjusted therapy upon identification and functional validation of a novel ALK resistance mutation in a case of lung adenocarcinoma by Arndt, Annette, Neumann, Christian, Riecke, Armin, Bauer, Arthur, Müller, Matthias, Wölfle-Guter, Manuela, Grunert, Michael, Busch, Hauke, Künstner, Axel, von Bubnoff, Nikolas, Fliedner, Stephanie, Greinert, Dina, Osius, Jasmin, Nagarathinam, Kumar, Steinestel, Konrad, Gorantla, Sivahari Prasad, Gebauer, Niklas, Witte, Hanno M

Get full text